{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:58:42Z","timestamp":1791111522595,"version":"4.1.0"},"reference-count":12,"publisher":"Informa Healthcare","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1517\/14740338.2014.904284","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T11:09:34Z","timestamp":1396350574000},"page":"675-680","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":22,"title":["Gliptins \u2013 do they increase cardiovascular risk or benefit?"],"prefix":"10.1517","volume":"13","author":[{"given":"Sheila A","family":"Doggrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon B","family":"Dimmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2014,4]]},"reference":[{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1198"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802743"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.207"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.920"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2010.05.2138"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307684"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12093"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305889"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.09.003"},{"key":"CIT0016","author":"Johansen OE","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12000"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.2014.904284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T14:00:37Z","timestamp":1481637637000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.2014.904284"}},"subtitle":["Evaluation of Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Eng J Med 2013;369:1317-26 and White WB, Cannon CP, Heller SR, et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 2013;369:1327-35."],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":12,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,4]]},"published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1517\/14740338.2014.904284"],"URL":"https:\/\/doi.org\/10.1517\/14740338.2014.904284","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}